Seegene(130,900 +1.39%)Announced on the 12th that sales based on consolidated financial statements for January-February this year increased 7.7 times from the same period last year to about 2236 billion won.
Bum-joon Kim, executive vice president of business administration, said, “Looking at the recently released data from the Korea Customs Service, we heard the voices of the market and shareholders expressing concerns about Seegene’s sales, and we are going to proceed with this disclosure to deliver the company value based on facts to the market.”
According to data from the Korea Customs Service, Seegene’s export performance as of January was 76.89 million dollars (about 86 billion won as of the date of departure). This is a difference of more than 40% compared to the consolidated sales of 127 billion won in January. Vice President Kim explained, “Since the data from the Korea Customs Service are based on customs clearance, only the export performance generated at the head office is reflected.” Consolidated sales reflect the earnings of domestic and overseas subsidiaries in addition to the exports of the head office.
“With the completion of the development of new products for diagnosing mutant coronavirus in January and February this year, exports of existing products in overseas markets temporarily decreased for product reorganization. As a result, sales did not meet expectations compared to the fourth quarter of last year.”
However, the company said that it is expected that sales will rise again from the second quarter if European use approval (CE-IVD) for two new products and equipment and supplies are supplied smoothly at the end of this month.
Reporter Minsoo Han [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution